Price target
7.170.000.00%
The 9 analysts offering 1 year price forecasts for 3320 have a max estimate of — and a min estimate of —.
Analyst rating
Based on 11 analysts giving stock ratings to 3320 in the past 3 months.
EPS
0.00
Reported
Estimate
Reported
Estimate
Surprise
Revenue
0.00
Reported
Estimate
Reported
Estimate
Surprise
This info isn't a recommendation for what you should personally do, so please don't take the data as investment advice. As with any trade, always look first, then leap. Read more in the Terms of Use.
Frequently Asked Questions
3320 EPS for the last quarter is 0.44 HKD despite the estimation of 0.46 HKD. In the next quarter EPS is expected to reach 0.23 HKD. Track more of CHINA RESOURCES PHARMACEUTICAL GR financials and stay on top of what is up with the company.
In the next quarter CHINA RESOURCES PHARMACEUTICAL GR revenue is expected to reach 136.52 B HKD. Check out CHINA RESOURCES PHARMACEUTICAL GR revenue and earnings and make informed decisions.
According to analysts, 3320 price target is 7.17 HKD with a max estimate of 9.73 HKD and a min estimate of 5.77 HKD. Check if this forecast comes true in a year, meanwhile watch CHINA RESOURCES PHARMACEUTICAL GR stock price chart and keep track of the current situation with 3320 news and stock market news.
We've gathered opinions of 11 analysts rating 3320 stock in the past 3 months. Most of them backed up the strong buy trend, and after taking into account other opinions, the overall rating was calculated as strong buy. Note that it's not a trading advice — your own analysis is still required.